NCT00516984

Brief Summary

The relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system is poorly understood. This study quantifies that relationship and demonstrates a cause and effect. It is hypothesized that cervical myofascial release increases vagal tone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Jan 2005

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

August 15, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 16, 2007

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

August 22, 2008

Status Verified

August 1, 2008

First QC Date

August 15, 2007

Last Update Submit

August 21, 2008

Conditions

Keywords

Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous systemLF/HF ratio

Outcome Measures

Primary Outcomes (1)

  • Normalized low frequency and high frequency components of HRV, including LF/HF ratio. Comparisons between measurements taken at a 50-degree tilt with those taken at pre- and post-intervention in the horizontal position.

    Treatments administered in separate sessions at least 24 hours apart.

Study Arms (3)

Placebo

PLACEBO COMPARATOR

No-touch control condition applied while subject was at a 50-degree head-up tilt.

Procedure: Placebo

Sham

SHAM COMPARATOR

Touch-only sham treatment applied while subject was at a 50-degree head-up tilt.

Procedure: Sham

OMT

ACTIVE COMPARATOR

Cervical myofascial OMT applied while subject was at a 50-degree head-up tilt.

Procedure: OMT

Interventions

PlaceboPROCEDURE

No-touch control condition applied while subject was at a 50-degree head-up tilt.

Placebo
ShamPROCEDURE

Touch-only sham treatment applied while subject was at a 50-degree head-up tilt.

Sham
OMTPROCEDURE

Cervical myofascial OMT applied while subject was at a 50-degree head-up tilt.

OMT

Eligibility Criteria

Age19 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • written informed consent
  • normal healthy adults older than 19 years and younger than 50 years
  • normal ECG
  • normal blood pressure based on criteria published in the Seventh Report of the U.S. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7).

You may not qualify if:

  • diabetes
  • asthma
  • pregnancy
  • smoking
  • premature ventricular contractions exceeding 20% of total heart beats
  • resting supine heart rate greater than 75 bpm or less than 45 bpm, systolic blood pressure greater than 140 mmHg or less than 90 mmHg
  • failure of heart rate to increase with passive tilt (50-degrees head-up)
  • Long-distance runners and other conditioned athletes also were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OSU

Tulsa, Oklahoma, 74107, United States

Location

Related Publications (1)

  • Henley CE, Ivins D, Mills M, Wen FK, Benjamin BA. Osteopathic manipulative treatment and its relationship to autonomic nervous system activity as demonstrated by heart rate variability: a repeated measures study. Osteopath Med Prim Care. 2008 Jun 5;2:7. doi: 10.1186/1750-4732-2-7.

MeSH Terms

Interventions

salicylhydroxamic acid

Study Officials

  • Charles E. Henley, D.O., MPH

    OUHSC

    PRINCIPAL INVESTIGATOR
  • Frances Wen, Ph.D.

    OUHSC

    PRINCIPAL INVESTIGATOR
  • Bruce Benjamin, Ph.D.

    OSU

    PRINCIPAL INVESTIGATOR
  • Douglas Ivins, M.D.

    OUHSC

    PRINCIPAL INVESTIGATOR
  • Miriam Mills, M.D.

    OSU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 15, 2007

First Posted

August 16, 2007

Study Start

January 1, 2005

Study Completion

October 1, 2007

Last Updated

August 22, 2008

Record last verified: 2008-08

Locations